This announcement is a separate document:
信立泰：华英证券有限责任公司关于深圳信立泰药业股份有限公司董事长叶宇翔先生在特定条件下拟参与控股子公司股权激励计划暨关联交易的核查意见
Xinlitai: Huaying Securities Co., Ltd.'s opinion on the inspection opinion of Mr. Ye Yuxiang, Chairman of Shenzhen Xinlitai Pharmaceutical Co., Ltd., to participate in the holding subsidiary's equity incentive plan and related transactions under specific c
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.